taking the medication to a smartphone application via a Bluetooth signal
The Food and Drug Administration (FDA) – the US drug agency – has just authorized the marketing in the US of this pill connected
It is the result of a collaboration between the Japanese laboratory Otsuka which manufactures antipsychotics and the Californian company Proteus Digital Health, which turns it into drug 2.0.
A micro-sensor – made of copper, silicone and magnesium – is integrated into the medication. As soon as it comes into contact with gastric juices, it sends an electrical signal to a patch placed on the body, which itself sends the date and time of taking the drug to a smartphone application via a Bluetooth signal. The subject can choose up to five people to send this information to. “Being able to track medication intake for a mental illness can be helpful for some patients,” says Mitchell Mathis, director of the psychiatric products division at the FDA’s Center for Drug Evaluation and Research.